On July 12, according to foreign media reports, sources said that Hema Xiansheng, a chain supermarket of Alibaba, is seeking funds and raised at a valuation of about $ 6 billion. Earlier, Bloomberg reported in January that Alibaba was considering seeking independent financing for Hema Xiansheng, and it was planned to be valued at $ 10 billion. That is to say, if the content of the report is true, Alibaba's valuation of Hema Xiansheng will be reduced by 40%.
The report shows that sources said that due to the epidemic, investors can maintain their growth in the loss of losing money and quickly achieve profitability. Alibaba has to reduce the valuation expectations of Hema Xiansheng.
Sources also said that Hema Xiansheng aims to raise 400 million to 500 million US dollars from external investors, but the fundraising is far from final determination, and the financial terms may change. Hema Xiansheng expressed welcoming excellent investors to help them develop, but added that they had a healthy cash flow and did not immediately raise the pressure of new funds.
Alibaba's earlier financial report shows that 12 months as of March 31, 2022, Alibaba's direct business and other revenue increased by 43%year -on -year to 260.955 billion yuan, mainly from Gaoxin Retail, Tmall Supermarket, Hema Ma Promoting the strong growth of the business. If the impact of merging Gaoxin retail is not considered, the year -on -year growth rate of direct operations and other income will be 28%.
Hema Xiansheng official website shows that Hema Xiansheng has 326 stores in 28 cities including Beijing, Shanghai, Shenzhen. Among them, Shanghai is the most concentrated city of Hema Xiansheng stores. Hema Xiansheng has 39 stores in Shanghai, accounting for about 22.39%of the total number of stores. (Liu Zhen)